Article info

Download PDFPDF

Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)

Authors

  1. a pdanaher{at}nanostring.com
  2. b swarren{at}nanostring.com
  3. c Rongze.lu{at}abbvie.com
  4. d josue.samayoa{at}abbvie.com
  5. e asullivan{at}nanostring.com
  6. f ipekker{at}nanostring.com
  7. g bwallden{at}nanostring.com
  8. h francesco.marincola{at}abbvie.com
  9. i +1-206-602-1701 acesano{at}nanostring.com
View Full Text

Citation

Danaher P, Warren S, Lu R, et al
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)

Publication history

  • Received March 2, 2018
  • Accepted May 25, 2018
  • First published June 22, 2018.
Online issue publication 
June 22, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.